Jenkem Technology Co Ltd
SSE:688356
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Jenkem Technology Co Ltd
Additional Paid In Capital
Jenkem Technology Co Ltd
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jenkem Technology Co Ltd
SSE:688356
|
Additional Paid In Capital
ÂĄ687.6m
|
CAGR 3-Years
115%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Additional Paid In Capital
ÂĄ14.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Additional Paid In Capital
ÂĄ1.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Additional Paid In Capital
ÂĄ3.1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
25%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Additional Paid In Capital
ÂĄ18.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
71%
|
CAGR 10-Years
31%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Additional Paid In Capital
ÂĄ858.7m
|
CAGR 3-Years
294%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Jenkem Technology Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
687.6m
CNY
Based on the financial report for Dec 31, 2022, Jenkem Technology Co Ltd's Additional Paid In Capital amounts to 687.6m CNY.
What is Jenkem Technology Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
58%
Over the last year, the Additional Paid In Capital growth was 5%. The average annual Additional Paid In Capital growth rates for Jenkem Technology Co Ltd have been 115% over the past three years , 58% over the past five years .